Chemokine Profiles Are Affected in Serum of Patients with Acute Rejection of Kidney Allograft
暂无分享,去创建一个
O. Viklicky | V. Švachová | I. Stříž | M. Fialová | L. Krupickova | M. Novotný | K. Mezerová | E. Cecrdlova | M. Fialova | E. Čečrdlová
[1] A. Perkowska-Ptasinska,et al. Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] C. Fischman,et al. Switching renal transplant recipients to belatacept therapy: results of a real-life gradual conversion protocol. , 2019, Transplant immunology.
[3] O. Elemento,et al. Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts. , 2019, JCI insight.
[4] R. Bonecchi,et al. Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy , 2019, Front. Immunol..
[5] T. Brunner,et al. Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factors. , 2019, Kidney international.
[6] G. Graham,et al. Chemokine Receptor Redundancy and Specificity Are Context Dependent , 2019, Immunity.
[7] D. Abramowicz,et al. Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies , 2019, Front. Med..
[8] W. Xue,et al. Multiple-biomarkers provide powerful prediction of early acute renal allograft rejection by combination of serum fractalkine, IFN-γ and IP-10. , 2018, Transplant immunology.
[9] A. Ridiandries,et al. The Role of Chemokines in Wound Healing , 2018, International journal of molecular sciences.
[10] I. Gibson,et al. The prognostic value of urinary chemokines at 6 months after pediatric kidney transplantation , 2018, Pediatric transplantation.
[11] W. Gong,et al. Chemokines in homeostasis and diseases , 2018, Cellular & Molecular Immunology.
[12] M. Stegall,et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] P. Nickerson,et al. Urinary CXCL10 Chemokine Is Associated With Alloimmune and Virus Compartment-Specific Renal Allograft Inflammation , 2017, Transplantation.
[14] I. Stříž. Cytokines of the IL-1 family: recognized targets in chronic inflammation underrated in organ transplantations. , 2017, Clinical science.
[15] Zilin Cui,et al. CXC Chemokine Receptor Type 4 Antagonism Ameliorated Allograft Fibrosis in Rat Kidney Transplant Model. , 2017, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.
[16] C. Shun,et al. CXCR4 Antagonist Reduced the Incidence of Acute Rejection and Controlled Cardiac Allograft Vasculopathy in a Swine Heart Transplant Model Receiving a Mycophenolate-based Immunosuppressive Regimen , 2017, Transplantation.
[17] M. Heinzelmann,et al. THP-1 cells as a model for human monocytes. , 2016, Annals of translational medicine.
[18] R. Pelletier,et al. Differential gene expression pattern in biopsies with renal allograft pyelonephritis and allograft rejection , 2016, Clinical transplantation.
[19] M. Cobbold,et al. The use of NGAL and IP‐10 in the prediction of early acute rejection in highly sensitized patients following HLA‐incompatible renal transplantation , 2014, Transplant international : official journal of the European Society for Organ Transplantation.
[20] A. Mantovani,et al. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors , 2014, Pharmacological Reviews.
[21] H. Wasmuth,et al. Chemokines in tissue fibrosis. , 2013, Biochimica et biophysica acta.
[22] B. McCormick,et al. Control of Neutrophil Inflammation at Mucosal Surfaces by Secreted Epithelial Products , 2013, Front. Immunol..
[23] N. Osada,et al. Systematic classification of vertebrate chemokines based on conserved synteny and evolutionary history , 2012, Genes to cells : devoted to molecular & cellular mechanisms.
[24] R. Koenen,et al. Touch of Chemokines , 2012, Front. Immun..
[25] P. Kubes,et al. Neutrophil‐active chemokines in in vivo imaging of neutrophil trafficking , 2012, European journal of immunology.
[26] A. Koch,et al. Pathological Role of Fractalkine/CX3CL1 in Rheumatic Diseases: A Unique Chemokine with Multiple Functions , 2012, Front. Immun..
[27] Stefan Offermanns,et al. International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B) , 2011, Pharmacological Reviews.
[28] A. Kirk,et al. Chemokines and Their Receptors in Human Renal Allotransplantation , 2011, Transplantation.
[29] R. Noelle,et al. Mast cell protease 6 is required for allograft tolerance. , 2010, Transplantation proceedings.
[30] M. Salvadori,et al. High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients , 2010, Transplant international : official journal of the European Society for Organ Transplantation.
[31] I. Stříž,et al. CXC and CC chemokines induced in human renal epithelial cells by inflammatory cytokines , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[32] C. Cheadle,et al. Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes. , 2009, Kidney international.
[33] H. Volk,et al. Intrarenal Cytokine and Chemokine Gene Expression and Kidney Graft Outcome , 2007, Kidney and Blood Pressure Research.
[34] H. Volk,et al. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. , 2006, Kidney international.
[35] M. Salvadori,et al. High Pretransplant Serum Levels of CXCL10/IP‐10 Are Related to Increased Risk of Renal Allograft Failure , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[36] Santa Jeremy Ono,et al. Chemokines: roles in leukocyte development, trafficking, and effector function. , 2003, The Journal of allergy and clinical immunology.
[37] M. Fishbein,et al. The role of MIG/CXCL9 in cardiac allograft vasculopathy. , 2002, The American journal of pathology.
[38] C. Weber,et al. Differential chemokine receptor expression and function in human monocyte subpopulations , 2000, Journal of leukocyte biology.
[39] F. Luscinskas,et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.